Canine Mammary Tumours (CMTs) exploit mitochondrial cholesterol for aggressive reprogramming

Key Points

• Canine mammary tumours exhibit aggressive reprogramming through enhanced mitochondrial cholesterol utilization, indicating their unique metabolic adaptations.
• Mitochondrial cholesterol's role in driving aggressive tumor behavior was demonstrated through experimental analyses within the tumor microenvironment.
• Targeting lipid metabolism pathways could provide new therapeutic strategies for treating canine mammary tumours, potentially improving outcomes.
• Highlights the potential for future studies to explore metabolic targeting, paving the way for innovative interventions in veterinary oncology.